Mon 12 14:30
OC3
Hyperprolactinaemia resistant to dopamine agonist due to an ectopic source of prolactin arising from a Uterine Tumour Resembling Ovarian Sex Cord Tumours (UTROCST)
Mon 12 16:15
OC7
Prolonged response to radiolabeled Yttrium90 DOTATATE in a patient with metastatic insulinoma – 5 years follow up
Mon 12 14:00
OC1
Testosterone secreting clear cell ovarian tumor in a patient with Von Hippel Lindau (VHL) disease
Mon 12 16:30
OC8
Recurrent severe hypoglycaemic episodes in the context of Insulin receptor antibodies
Mon 12 14:45
OC4
Management of massive (up to 550 mm) bilateral adrenal masses in a non-adherent patient with 21-hydroxylase deficiency congenital adrenal hyperplasia:complex risk benefit analysis
London, United Kingdom
Mon 12 14:15
OC2
Episodic primary aldosteronism associated with a novel gain-of-function mutation in a cell adhesion molecule
London, United Kingdom
Workshop
0
Oral
0
Expert
0
Plenary
0
Catering and Social
0
Nurse
0
Other
0
Symposium
0
No Session Type
6
Mon 12 14:00
OC1
Testosterone secreting clear cell ovarian tumor in a patient with Von Hippel Lindau (VHL) disease
Mon 12 14:15
OC2
Episodic primary aldosteronism associated with a novel gain-of-function mutation in a cell adhesion molecule
London, United Kingdom
Mon 12 14:30
OC3
Hyperprolactinaemia resistant to dopamine agonist due to an ectopic source of prolactin arising from a Uterine Tumour Resembling Ovarian Sex Cord Tumours (UTROCST)
Mon 12 14:45
OC4
Management of massive (up to 550 mm) bilateral adrenal masses in a non-adherent patient with 21-hydroxylase deficiency congenital adrenal hyperplasia:complex risk benefit analysis
Mon 12 16:15
OC7
Prolonged response to radiolabeled Yttrium90 DOTATATE in a patient with metastatic insulinoma – 5 years follow up
Mon 12 16:30
OC8
Recurrent severe hypoglycaemic episodes in the context of Insulin receptor antibodies
0 result(s) found.